About Spinnotec
Spinnotec is a private equity firm founded in 1999. It is primarily based in Shanghai, China.
Overall Spinnotec portfolio has seen 1 unicorn, 23 IPOs and 3 acquisitions including key companies like VeriSilicon, WuXi AppTec and Qihoo 360 Technology. A lot of funds co-invest with Spinnotec, with names like CICC Capital sharing a substantial percentage of its portfolio.
Spinnotec has a team of 10 people, including 5 partners.
Key Metrics
Spinnotec's Portfolio
They have invested in a total of 131 companies. Their most recent investment was in Weidu Semiconductor (Series A round) on Oct 13, 2022. Here is the most recent investment by Spinnotec:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Oct 13, 2022 | Series A | 5677 | ||
Aug 18, 2022 | Series C | 4081 | ||
Nov 01, 2021 | Series A | 8915 | ||
Oct 20, 2021 | Seed | 1639 |
Here is the portfolio snapshot of Spinnotec:
Investments by Year
The maximum number of investments were made in 2019
Team profile of Spinnotec
Spinnotec has a team of 10 members including 5 Partners and 1 Principal located in China. Spinnotec's team does not sit on the board of any company as of now.Here is a list of all team members in Spinnotec:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | ||
Partner | - | - | ||
Partner | - | - | ||
Partner | - | - | ||
Partner | Pudong | - | ||
Principal | Pudong | - | ||
Associate | Pudong | - | ||
Associate | Pudong | - | ||
Associate | Pudong | - | ||
Associate | Pudong | - |
Co-investors of Spinnotec
Over the past 27 years, 67 investors have co-invested in Spinnotec's portfolio companies.
- Top Co-investors of Spinnotec: 67 investors entered a company along with Spinnotec. These include investors like CICC Capital (2 companies).
Spinnotec News
•
Vision Bio completes 300 million yuan round D financing36Kr•Apr 18, 2021•VivaVision Biotech, Sequoia Capital, FengHe Group, Spinnotec and 1 other
•
3D Medicines' new financing round reaches 1.5b yuanChina Daily•Oct 19, 2020•3DMed, CPE Capital, Jemincare, Tsing Capital and 10 others
•
InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL VenturesPR Newswire•Sep 27, 2020•InventisBio, GL Ventures, Qiming Venture Partners, Janchor Partners and 14 others
•
Cell and gene therapy drug developer "Heyuan Bio" completed a pre-C round of financing of about 200 million yuan, led by Yifeng CapitalLieyunwang•Jul 07, 2020•And Yuan Biotechnology, Shengshan Capital, Shanghai Zhangjiang Technology Venture Capital, Shanghai Pudong Science Technology Investment and 4 others
•
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C FinancingPR Newswire•Mar 11, 2019•InventisBio, Advantech Capital, CMB International Capital, Orbimed and 2 others
